suggest that the acute inactivation of the VHL gene contributes to protective effects of ischemic preconditioning in renal tubules of the mouse.
Introduction
Hypoxia in the tubulointerstitium has been thought to play pivotal roles in the pathophysiology of acute renal failure. Ischemic acute renal failure is traditionally referred to as acute tubular injury [1] . Proliferation of affected tubular cells seems to be essential for timely recovery of tubules after acute renal damage and for subsequent functional recovery of the injured kidney [2] . The identification of the mechanisms responsible for the ischemic tubular damage is important not only for an understanding of the pathophysiology of ischemic injury, but also for considering therapeutic strategies. Although the pathogenesis of human acute tubular injury is not fully understood, a number of animal studies have shown that several kinds of mediators can be involved in ischemiareperfusion injury (IRI) in renal tubules [2] [3] [4] [5] [6] [7] [8] .
Many processes of adaptation to hypoxia are mediated by hypoxia-inducible factor (HIF), which is a master reg-e83 ulator of genes transactivated by low oxygen tension. The level of HIF-1 ␣ protein, an oxygen-regulated component of HIF-1, is tightly regulated by von Hippel-Lindau protein (pVHL). pVHL forms a complex with HIF-1 ␣ during normoxic conditions, but not in ischemic hypoxia, and then rapidly induces ubiquitin-mediated degradation of HIF-1 ␣ [9, 10] . Several published studies indicate that pre-induction of HIF-1 ␣ before pathological insult activates a self-defense mechanism and suppresses further aggravation of organ or cellular injury by ischemia [11] [12] [13] [14] . One previous report concluded that pretreatment with cobalt, which inhibits HIF-1 ␣ degradation and elevates its protein level, protected against subsequent renal tubular damage in rats with glomerular injury [14] . Furthermore, these authors have recently demonstrated a pivotal role for HIF-2 ␣ in IRI using HIF-2 ␣ knockdown mice [15] . HIF-2 ␣ is known as another target of pVHL, but plays different roles and possesses contrasting properties compared with HIF-1 ␣ in terms of expression levels and localization [16] [17] [18] . Although the roles of HIF-1 ␣ and HIF-2 ␣ were extensively investigated in these previous studies, especially under hypoxic conditions, the role of pVHL remains unclear in the progression of renal tubular damage induced by IRI.
Given the potential importance of pVHL during ischemic conditions, we used VHL conditional knockout (VHL-KO) mice that expressed an inducible Cre recombinase transgene (CreER TM ) [19] to delete the floxed VHL gene in an acute manner following tamoxifen induction. We then investigated whether pre-inactivation of VHL would afford protection of renal tubules from injury during IRI.
Materials and Methods
NCI-Frederick is accredited by AAALAC International and follows the Public Health Service Policy for the Care and Use of Laboratory Animals. Animal care was provided in accordance with the procedures outlined in the 'Guide for Care and Use of Laboratory Animals' (National Research Council, 1996; National Academy Press, Washington, D.C., USA).
Generation of VHL-KO Mice
Mice carrying the VHL conditional (floxed) allele were generated by Ma et al. [20] [19] , and selected for VHL f/d /CreER TM offspring by PCR-based genotyping [21] . As already reported, Cre recombinase expression in this system is under the control of a human ␤ -actin promoter. Therefore, Cre recombinase was expressed throughout the kidney as demonstrated by using ROSA26 reporter mice ( fig. 1 a) . Based on the data reported by Hong et al. [21] , we determined the least toxic concentration of tamoxifen that was still effective in inducing Cre recombination. For our experiments, VHL f/d /CreER TM mice were injected i.p. with tamoxifen in corn oil (0.36 mg/g body weight) to activate Cre recombinase 1 week prior to renal IRI. Eight to fifteen-week-old male and female VHL f/d /CreER TM mice (n = 10) and littermate VHL f/+ /CreER TM control mice (n = 6) were subjected to tamoxifen induction for these experiments. Mice were housed in a specific pathogen-free facility and were confirmed to be negative for common murine viral pathogens by routine sera analysis.
Western Blot Analysis
Protein from whole murine kidneys was prepared using Tissue Protein Extraction Reagent (Pierce Biotechnology, Rockford, Ill., USA). Western blot analysis was performed according to the methods in our previous study [22] . Kidney extracts were mixed with sample buffer, separated by electrophoresis on SDS-PAGE gels and then transferred to PolyVinylidine DiFluoride membranes (Immobilon-P; Millipore, Bedford, Mass., USA). A rabbit polyclonal anti-VHL antibody (1: 100; BD Biosciences, San Jose, Calif., USA), a mouse monoclonal anti-HIF-1 ␣ antibody (1: 500; Novus Biologicals, Littleton, Colo., USA), a rabbit polyclonal anti-HIF-2 ␣ antibody (1: 500; Novus Biologicals), a rabbit polyclonal anti-erythropoietin antibody (1: 500; Santa Cruz Biotechnology, Santa Cruz, Calif., USA), a mouse monoclonal anti-␣ -tubulin antibody (1: 1,000; Lab Vision, Fremont, Calif., USA) and a mouse monoclonal anti-heme oxygenase (HO)-1 antibody (1: 1,000; Stressgen, Ann Arbor, Mich., USA) were used with a horseradish peroxidase-conjugated secondary antibody (Promega, Madison, Wisc., USA). The ECL Plus Western blotting system (Amersham Bioscience, Piscataway, N.J., USA) was used for detection.
RT-PCR
Total RNA were isolated from mouse kidney using Trizol reagent (Invitrogen) according to the manufacturer's instructions. To remove genomic DNA contamination, RNA were digested with DNase I for 1 h at 37 ° C, followed by heat denaturation at 70 ° C for 20 min. Total RNA (2.5 g) were primed with 100 ng random primers and reverse-transcribed by Superscript II reverse transcriptase (Invitrogen, Carlsbad, Calif., USA) at 42 ° C for 1 h. The same reactions were performed without reverse transcriptase to generate negative controls. The following PCR primers were generated by using Primer 3 software [21] : VEGF forward, 5 -CAGGCTGCTGTAACGATGAA-3 ; VEGF reverse, 5 -TATGT-GCTGGCTTTGGTGAG-3 ; ␤ -actin forward, 5 -GACAGGAT-GCAGAAGGAGATTACTG-3 ; ␤ -actin reverse, 5 -GCTGATC -CACATCTGCTGG AA-3 .
Quantitative RT-PCR was performed with SYBR-Green reagent (Applied Biosystems) with the ABI PRISM sequence detection system (Applied Biosystems Inc., Foster City, Calif., USA) following the manufacturer's instructions. All reactions were run in triplicate using the ␤ -actin gene as an internal control.
Antibody Microarray Analysis
In order to detect the proteins that were selectively expressed in the VHL -KO mouse kidney, but not in control mouse kidney after tamoxifen induction, the Panorama Cell Signaling Anti-e84 body Microarray Kit (CSAA1; Sigma-Aldrich, Saint Louis, Mo., USA) was used to detect a wide variety of proteins responsible for a broad range of biological functions, including apoptotic and cell cycle proteins. The antibody microarray was composed of 224 specific antibodies responsible for cell signaling, which were spotted in duplicate on nitrocellulose-coated glass slides. We prepared cell lysates from each kidney, and the lysates were blotted according to manufacturer's protocols. The complete list of arrayed antibodies can be found at the Sigma-Aldrich website:
http://www.sigmaaldrich.com/catalog/search/ProductDetail/SIGMA/CSAA1.
Induction of IRI
The mice to be analyzed were anesthetized by i.p. injection of pentobarbiturate (4 mg/kg). Following abdominal incisions, the bilateral renal arteries were occluded at the proximal ends of the abdominal aorta with arterial clips for 30 min. After removal of the clips, the kidneys were checked for reperfusion. Twenty-four hours later, the mice were sacrificed for further sampling, and blood was collected for evaluation of renal function.
Assessment of Renal Function
Blood urea nitrogen (BUN) and creatinine (CRN) levels were measured for assessment of the renal function. BUN and CRN levels were analyzed by automated analysis (Hitachi 7350; Hitachi, Ibaraki, Japan) in our laboratory center.
Histological Analysis
To evaluate the kidney damage induced by renal IRI, histological analysis was performed. Four-micrometer paraffin sections were stained with hematoxylin and eosin (HE). On the basis of the method described by Matsumoto et al. [14] , we evaluated the morphological changes in renal tubules. Tubular injury was scored by estimating the percentage of injured tubules in the outer medulla and corticomedullary junction that showed tubular dilation, tubular epithelial injury, debris accumulation, and cast formation as follows: 0 normal; 1 mild; 2 moderate; 3 severe. Twenty viewing fields randomly selected from the outer medulla and corticomedullary junction on each slide section were examined at ! 400 magnification. One slide per mouse kidney was evaluated.
Immunohistochemical Analysis
An immunohistochemical study was performed on paraffin sections of mouse kidneys using the Ventana automated immunohistochemistry system (Discovery TM ; Ventana Medical Systems, Inc., Tucson, Ariz., USA). VHL was identified with a polyclonal anti-VHL antibody, sc-5575 (1: 150; Santa Cruz Biotechnology). Antigen retrieval was performed for 60 min in a preheated Dako Target Retrieval Solution (pH 6.0; Dako, Glostrup, Denmark) using microwave treatment, followed by further steps including inhibition of intrinsic peroxidase, and blocking and reaction with a primary antibody.
Terminal Deoxynucleotide Transferase dUTP Nick-End Labeling Staining
Terminal Deoxynucleotide Transferase dUTP Nick-End Labeling (TUNEL) assay was performed to detect apoptosis in situ. Renal tissue sections were deparaffinized and rehydrated through 3 changes between xylene and graded alcohol, later washed in phosphate-buffered saline (PBS) for 5 min, and then incubated in 20 g/ml proteinase K for 15 min at room temperature. ApopTag Peroxidase In Situ Apoptosis Detection Kit (S7100; Chemicon International, Temecula, Calif., USA) was used according to the manufacturer's instructions. Endogenous peroxidase activity in the kidney sections was blocked by incubation for 5 min with 3% H 2 O 2 in PBS, followed by incubation with equilibration buffer for 10 s. The sections were then incubated for 60 min at 37 ° C with terminal deoxynucleotidyl transferase enzyme in reaction buffer. The reaction was finished by incubation with stopping buffer at room temperature. Sections were incubated with peroxidase-conjugated anti-digoxigenin antibody for 30 min at room temperature, and the reaction was developed with diaminobenzidine substrate for 6 min at room temperature. Sections were counterstained with methyl green stain, dehydrated through a graded series of alcohol, and mounted for microscopy viewing.
Statistical Analysis
Data are reported as means 8 standard error of the mean (SEM). An unpaired t test was used for paired samples, and Student's t test was used to compare the 2 groups. A p value of ! 0.05 was considered statistically significant.
Results

Expression Level of VHL Protein in VHL-KO Mice
To examine the distribution of Cre recombinase expression in the kidney for evaluating regions of VHL deletion, ROSA26 reporter mice were used. As shown in figure 1 fig. 1 b) . pVHL was detected in kidneys of control mice, but significantly reduced expression levels of VHL protein were detected in VHL-KO kidneys. In contrast to the VHL expression pattern, the protein levels of HIF-1 ␣ and HIF-2 ␣ were elevated in VHL-KO kidneys compared with control kidneys ( fig.  1 b) . These results demonstrated the effectiveness of the tamoxifen-inducible VHL conditional knockout mouse system, which causes VHL inactivation and stabilization of HIF-1 ␣ and HIF-2 ␣ protein, following tamoxifen injection.
To further evaluate HIF ␣ -inducible target genes, the protein levels of HO-1 and erythropoietin were compared with gene expression levels of VEGF. As demon-e85 strated in figure 1 c, they were elevated in VHL-KO kidneys compared with control kidneys.
BUN and CRN Levels in VHL-KO and Control Mouse Kidneys after IRI
To assess whether VHL inactivation might play a role in renal protection during renal IRI, we subjected tamoxifen-injected VHL f/d /CreER TM (VHL-KO) and control mice to renal IRI by clamping the bilateral renal arteries. This procedure consisted of 30 min of ischemia followed by 24 h of reperfusion. IRI significantly impaired renal function in control mice, as indicated by elevated serum BUN and CRN levels after 24 h of reperfusion. The BUN and CRN levels in control mice (n = 6) were 138.10 8 13.03 mg/dl and 0.72 8 0.16 mg/dl, respectively. In contrast, serum BUN and CRN levels in VHL-KO mice (n = 10) were 52.12 8 6.61 mg/dl and 0.24 8 0.04 mg/dl, respectively. There were significant differences in the levels of these renal function markers in VHL-KO mice compared with control mice ( fig. 2 a, b) . Compared to control mice, VHL-KO mice demonstrated a dramatic reduction in BUN and CRN levels (p ! 0.05 for each comparison), suggesting that VHL inactivation had contributed to protection of renal function following renal IRI. 
Histological Analysis of the VHL-KO and Control Mouse Kidneys after IRI
Impairment of renal function, as assessed by BUN and CRN levels, was corroborated by histological evidence. By HE staining, more severe tubular damage was detected in tamoxifen-treated control kidney sections with extensive proximal tubular injury including tubular dilatation and tubular epithelial degeneration with necrosis ( fig. 3 a) . In contrast, tamoxifen-injected VHL-KO mice subjected to renal IRI showed less proximal tubular injury with even milder tubular epithelial degeneration in the kidney sections ( fig. 3 b) . Proximal tubular damage was mainly observed from the outer medulla to the medullary ray of the cortex in control mice. No regions of necrotic debris or cast in the damaged tubules were detected in the sections from either VHL-KO or control kidneys. Compatible with the pathological changes in the control kidney, positive cells in TUNEL staining were detected in those regions; however, no TUNEL positive cells were detected in the VHL-KO kidney ( fig. 3 e) . Semi-quantitative analysis of tubular damage demonstrated that the levels of tubular injury scores were significantly higher in control mice (n = 6) than in VHL-KO mice (n = 10; p ! 0.05; fig. 3 e) . The scores in control mice and VHL-KO mice were 2.40 8 0.08 and 0.90 8 0.12, respectively. No pathological lesions of glomeruli and negligible numbers of infiltrated inflammatory cells were observed in VHL-KO and control kidney sections.
Immunohistochemical Analysis of the Tamoxifen-Injected VHL-KO and Control Mouse Kidneys after IRI
To further investigate the relationship between the localization of IRI-induced renal lesions and the distribution of VHL protein immunoreactivity in the kidneys, we performed immunohistochemical analysis of the VHL protein. The immunoreactivity of pVHL using anti-VHL antibody was mainly and strongly detected in the tubules of the tamoxifen-treated control mouse kidneys after renal IRI ( fig. 3 c) . In contrast, however, extremely weak immunoreactivity of pVHL was detected in the tubules of the tamoxifen-treated VHL -KO mice ( fig. 3 d) . We failed to detect pVHL immunoreactivity in glomeruli of either VHL -KO or control mice. TUNEL staining revealed positive apoptotic cells in the proximal tubules with the immunoreactivity of pVHL of the tamoxifen-treated control mouse kidneys after renal IRI ( fig. 3 e) , while there were almost no positive cells in VHL-KO mice.
Antibody Microarray Analysis of VHL-KO and Control Mouse Kidneys after IRI
In order to investigate downstream signaling molecules that may contribute to renal protection from IRI as a consequence of VHL inactivation, we used an antibody microarray containing 224 cell signaling proteins to compare the relative expression levels of these proteins in VHL-KO and control kidneys following tamoxifen induction. Proteins showing a 1 1.5-fold difference in expression were considered significantly differentially expressed. We observed an increase in protein expression 
Discussion
To date, there have been no representative studies in the nephrology field that extensively investigated the role of VHL protein in renal injuries induced by ischemia. In this study, using murine genetic approaches, we have used a conditional VHL-KO mouse model based on the tamoxifen-inducible CreER TM system to inactivate the VHL gene in an acute manner during ischemia caused by bilateral renal IRI.
Here, we demonstrated that VHL-KO mice subjected to renal IRI had extremely mild renal tubular injury without significant increases in BUN and CRN, while severe tubular damage and significantly higher levels of BUN and CRN were detected in control kidneys. Our histological analysis and evaluation of renal function showed that VHL inactivation could ameliorate ischemia-reperfusion injury of mouse renal tubules.
Matsumoto et al. [14] reported that the most severe damage resulting from ischemic insult in a rat model extended from the outer medulla to the medullary ray of the cortex, suggesting that the proximal S3 segment and the thick ascending limb of the nephron are susceptible to ischemic injury. Consistent with these findings, we frequently observed severe damage to the proximal tubules histologically in control mice. Furthermore, under normal conditions, VHL protein displays an expression pattern restricted to the proximal tubules of the kidney [23] [24] [25] . Our immunohistochemical analysis demonstrated that pVHL expression was detected strongly in the proximal tubules of the control kidneys, which coincided with the regions showing sustained moderate to severe injury after renal IRI. TUNEL staining of the tamoxifen-treated control mouse kidneys after renal IRI also revealed positive apoptotic cells in the proximal tubules with pVHL expression. In contrast, only weak immunoreactivity to VHL protein was found in the VHL-KO mouse kidney tubules that showed no damage.
Although the mechanisms are not fully elucidated in the present study, taken together these findings suggest that reduced expression of VHL protein in renal proximal tubules of VHL-KO mice could inhibit the transition to acute tubular injury. Our antibody microarray data indicate that inactivation of VHL leads to upregulation of several proteins reported to be responsible for activation of cell survival and inhibition of apoptosis (i.e. Aop-1, NAK, Cdc7 kinase), suggesting that renal protection resulting from VHL inactivation may involve signaling through these pathways. Nonetheless, the finding that VHL-KO mice were significantly less susceptible to renal IRI compared with control mice suggests that acute inactivation of the VHL gene contributes to protective effects against ischemic damage to renal tubules of VHL-KO mice.
Using this CreER TM system, in vivo deletion of the VHL gene leads to increases in VHL target proteins HIF-1 ␣ and HIF-2 ␣ . Recently, it has been reported that HIF-2 ␣ is also involved in adaptation to hypoxic conditions [15] [16] [17] [18] . Unlike HIF-1 ␣ , HIF-2 ␣ is known to be restricted in expression to only a few types of cells including endothelial cells, and it was reported that loss of HIF-2 ␣ resulted in functional disruption of the endothelium [15] . In contrast to that study, which used HIF-2 ␣ knockdown mice, our VHL conditional knockout mice kidneys showed increased expression of both HIF-1 ␣ and HIF-2 ␣ proteins. Therefore, it is suggested that elevation of those HIF ␣ subunits partly contributes to attenuation of IRI. In addition, other than the HIF ␣ -dependent processes, HIF ␣ -independent effects of VHL must also be taken into account. Several lines of evidence support a role for VHL in maintenance of epithelial tissue architecture and extracellular matrix deposition [26] [27] [28] , suggesting that VHL may also be involved in inhibition of the cell cycle and, consequently, loss of pVHL might activate cell proliferation signals. Therefore, in our study both HIF ␣ -dependent and -independent processes might contribute to the final phenotype in VHL-KO mice. The present results also support our previous findings in another animal model, a rat model of glomerulonephritis, in which we demonstrated that VHL preinduction by thrombin, a recently identified VHL inducer, aggravates glomerulonephritis [23] . Although the significance of VHL induction may vary in different animal models and cell types, our findings in the rat model suggest that VHL induction puts the kidney at a disadvantage, and may be a reflection of the results presented here.
Several published reports have indicated that preinduction of HIF-1 ␣ before pathological insult activates a self-defense mechanism and suppresses further aggravation of organ or cellular injury [11] [12] [13] . We have also previously shown that HIF-1 ␣ pre-induction by chemical hypoxia remarkably attenuated glomerulonephritis progression [24] . Furthermore, our recent studies demonstrated that HIF-1 ␣ was increased in VHL-null cells, even under normoxia, and directly enhanced apoptosis inhibitor gene expression, which suppresses mitochondrial function and reduces oxygen consumption [29] . Since the proximal tubules are rich in mitochondria for active transport, and therefore oxygen demand is elevated, these regions with enhanced VHL expression levels are more susceptible to hypoxic events. Therefore, based on our recent study [29] , it is suggested that VHL inactivation leads to HIF ␣ stabilization, resulting in suppression of mitochondrial function and up-regulation of glucose metabolism. Our previous findings may suggest a possible mechanism, in the present study, by which VHL inactivation in the tamoxifen-inducible VHL-KO mice was protective against renal tubular injury. Bearing in mind that pVHL plays an important role in regulating the HIF ␣ protein levels, reduction of VHL protein levels appears to be a positive modulator of survival signals in renal tubular cells. However, our data does not exclude the possibility that prolonged ischemia in VHL-KO mice may lead to the activation of HIF-1 ␣ -regulated growth factors, such as EPO, PDGF, and TGF ␣ , which could override these protective effects against renal tubular injuries, since other reports show that a broad variety of inflammatory mediators and cytokines can regulate HIF-1 ␣ , which in turn negatively controls inflammatory processes, and such a mechanism might be involved in protection from IRI [30, 31] . Further studies in VHL-KO mice are needed to define additional signal transduction pathways involved in renal tubular protection from the ischemic assault.
In conclusion, we have shown that VHL-KO mice, in which acute VHL inactivation was induced by tamoxifen injection, were much less susceptible to renal IRI than control mice. This inducible VHL -inactivation system should prove useful as an in vivo model for evaluating drugs that can target HIF and HIF-regulated genes such as VEGF under ischemic conditions. Our present study has demonstrated a correlation between loss of VHL expression and protection against renal tubular injuries induced by ischemia. Further study is needed to elucidate the mechanisms by which VHL inactivation initiates cell signaling leading to renal tubule protective effects during renal IRI.
